Zhejiang Starry Pharmaceutical Co., Ltd.

W1G12
China Mainland
Company Profile
  • Year Established: 1997
  • Total Assets(USD): Choose not to disclose
  • Total Number of Staff: more than 500
  • Business Type: Manufacturer
  • Annual Turnover(USD) : 75,000,000 to 79,999,999
  • Main Sales Markets : Central/South America,Eastern Europe,Asia,Middle East

Starry Pharm is the largest manufacturer of X-CT non-ionic and MRI Contrast Medium in China. Main products have GMP certificate, COS and Japanese PMDA qualified and so on. At present, the integrated layout of intermediates, APIs, and preparations has been completed, and the finished products of iohexol, iopamidol, iodixanol and iomeprol injection have passed the consistency evaluation, and particularly iomeprol injection is the first generic in China

Year Established: 1997

Total Assets(USD): Choose not to disclose

Total Number of Staff: more than 500

Business Type: Manufacturer

Annual Turnover(USD) : 75,000,000 to 79,999,999

Main Sales Markets : Central/South America,Eastern Europe,Asia,Middle East

Top Products
Copyright 2006-2022 Shanghai Sinoexpo Informa Markets International Exhibition Co. Ltd (All Rights Reserved) 沪ICP备05034851号-182
Powered by